These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 5233029)
1. Vascular insufficiency and Heberden's nodes. A possible etiologic factor. Hunter W J S C Med Assoc; 1967 May; 63(5):165-9. PubMed ID: 5233029 [No Abstract] [Full Text] [Related]
2. Investigations in generalized osteoarthritis. Part 1: genetic study of Heberden's nodes. Irlenbusch U; Schäller T Osteoarthritis Cartilage; 2006 May; 14(5):423-7. PubMed ID: 16443379 [TBL] [Abstract][Full Text] [Related]
3. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders]. Hamming JJ; van der Drift JH Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995 [No Abstract] [Full Text] [Related]
4. [Vasodilators. 2-Treatment of arterial hypertension, cardiac insufficiency and peripheral vascular diseases]. Langlois S; Ogilvie RI Union Med Can; 1981 Oct; 110(10):850-6. PubMed ID: 7303307 [No Abstract] [Full Text] [Related]
5. Heberden's and Bouchard's nodes. Alexander CJ Ann Rheum Dis; 1999 Nov; 58(11):675-8. PubMed ID: 10531070 [No Abstract] [Full Text] [Related]
6. [Vasodilator agents]. Bollinger A Schweiz Med Wochenschr; 1967 Sep; 97(37):1225-7. PubMed ID: 4874428 [No Abstract] [Full Text] [Related]
10. Treatment of vascular diseases with Mydocalm. Sztankay C Ther Hung; 1970; 18(3):121-4. PubMed ID: 5496813 [No Abstract] [Full Text] [Related]
11. Vascular diseases: new results with pentoxifylline. Belcaro G; Cesarone MR; Ippolito E Angiology; 2002; 53 Suppl 1():1 p following TOC. PubMed ID: 11863316 [No Abstract] [Full Text] [Related]
12. [Vasodilators. Clinical effect in peripheral vascular disorders. A survey of the literature]. Hallén LG Lakartidningen; 1965 Sep; 62(39):3149-52. PubMed ID: 5330352 [No Abstract] [Full Text] [Related]
13. Medical therapy in arterial disorders of the extremities: Vasodilator drugs. Myers KA Mod Treat; 1967 Mar; 4(2):370-85. PubMed ID: 5341885 [No Abstract] [Full Text] [Related]
14. The influence of vasodilator drugs on walking, in chronic occlusion of the leg arteries. Schlüssel H Angiologica; 1966; 3(6):370-6. PubMed ID: 5958239 [No Abstract] [Full Text] [Related]
15. The use and abuse of vasodilator drugs. Rose SS Vasc Dis; 1967 Apr; 4(2):67-82. PubMed ID: 6027150 [No Abstract] [Full Text] [Related]
16. [Our experience in the treatment of peripheral vascular diseases with raubasine]. Vercellio G; Costantini S; Giulini S Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726 [No Abstract] [Full Text] [Related]
17. [Treatment of peripheral vascular disorders with dilatol]. Knapik Z; Twardzicki J; Wlodarczykowa J Pol Tyg Lek; 1965 Jun; 20(23):846-8. PubMed ID: 5841123 [No Abstract] [Full Text] [Related]
18. [Experience with the vasodilator agent spasmocyclone]. Priessnitz O Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718 [No Abstract] [Full Text] [Related]
19. [Can the Doppler method indicate the usefulness of vasodilator therapy?]. Bartolo M; Antignani PL Recenti Prog Med; 1981 Aug; 71(2):175-84. PubMed ID: 7313287 [No Abstract] [Full Text] [Related]
20. [Conservative therapy of arterial occlusive diseases on a rational basis]. Alexander K Dtsch Med J; 1972 May; 23(5):343-8. PubMed ID: 5036945 [No Abstract] [Full Text] [Related] [Next] [New Search]